by Steven D. Targum, MD, and Dan V. Iosifescu, MD, MSc

Dr. Targum is an executive-in-residence at Oxford BioScience Partners and on the faculty of the Department of Psychiatry at the Massachusetts General Hospital. Dr. Targum is chief medical officer at BrainCells Inc., and chief medical advisor to Prana Biotechnology Ltd. Dr. Targum is on the editorial board of Psychiatry 2009. Dr. Iosifescu is director of Translational Neuroscience in the Depression Clinical and Research Program, site director of the Bipolar Trials Network at Massachusetts General Hospital., and assistant professor of psychiatry at Harvard Medical School.

Popularity: unranked [?]

Related posts:

1. Revisiting the Clinical Utility of Cytochrome p450 in Practice
2. Comorbid Adolescent Substance Use and Major Depressive Disorders:
3. The Clinical Global Impressions Scale: Applying a Research Tool in Clinical Practice
4. Baby Stimuli and the Parent Brain: Functional Neuroimaging of the Neural Substrates of Parent-Infant Attachment